Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOSEPH GELBFISH

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1417058165
CMS profile
64129
Location
BROOKLYN, NY

General Payments · PY2018–2024

$4,160.90

  • Reported across 201 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$414.73

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $414.73 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $125.00 1
PFIZER INC. $75.44 4
Acerta Pharma LLC $63.47 3
NOVARTIS PHARMACEUTICALS CORPORATION $60.65 2
E.R. Squibb & Sons, L.L.C. $54.16 2
Medtronic, Inc. $20.01 1
Amgen Inc. $16.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $844.11 43
PY2019 $773.30 40
PY2020 $523.71 27
PY2021 $572.94 30
PY2022 $561.54 26
PY2023 $470.57 21
PY2024 $414.73 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $16.00 11/04/2024 Food and Beverage Undisputed 01/23/2026 1111581888 CMS
AstraZeneca Pharmaceuticals LP $20.70 02/05/2024 Food and Beverage Undisputed 01/23/2026 1104206457 CMS
AstraZeneca Pharmaceuticals LP $22.88 05/06/2024 Food and Beverage Undisputed 01/23/2026 1104530988 CMS
AstraZeneca Pharmaceuticals LP $19.89 09/18/2024 Food and Beverage Undisputed 01/23/2026 1105573983 CMS
E.R. Squibb & Sons, L.L.C. $35.67 02/28/2024 Food and Beverage Undisputed 01/23/2026 1101216904 CMS
E.R. Squibb & Sons, L.L.C. $18.49 09/11/2024 Food and Beverage Undisputed 01/23/2026 1101216954 CMS
Medtronic, Inc. $20.01 11/06/2024 Food and Beverage Undisputed 01/23/2026 1119307832 CMS
Novartis Pharmaceuticals Corporation $29.96 02/12/2024 Food and Beverage Undisputed 01/23/2026 1086846517 CMS
Novartis Pharmaceuticals Corporation $30.69 04/08/2024 Food and Beverage Undisputed 01/23/2026 1086846521 CMS
PFIZER INC. $16.48 01/29/2024 Food and Beverage Undisputed 01/23/2026 1131006716 CMS
PFIZER INC. $16.59 06/03/2024 Food and Beverage Undisputed 01/23/2026 1131678504 CMS
PFIZER INC. $17.42 09/23/2024 Food and Beverage Undisputed 01/23/2026 1131966165 CMS
PFIZER INC. $24.95 12/16/2024 Food and Beverage Undisputed 01/23/2026 1131418978 CMS
Teva Pharmaceuticals USA, Inc. $125.00 01/18/2024 Food and Beverage Undisputed 01/23/2026 1151508966 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.